HomeAI · summaries
Storia in 2 fonti
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
theverge.com
Anthropic wants to develop its own drugs
The AI drug boom has a long way to go before reaching patients.
- ·
the-decoder.com
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could…